Skip to main content

IDH2 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP1-52117

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP1-52117

Key Product Details

Species Reactivity

Human, Mouse, Rat, Porcine

Applications

Immunohistochemistry, Immunohistochemistry-Paraffin, Peptide ELISA, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG

Concentration

0.5 mg/ml

Product Specifications

Immunogen

Peptide with sequence CIHGLSNVKLNE corresponding to internal region according to NP_002159.2.

Epitope

CIHGLSNVKLNE

Reactivity Notes

Expected from sequence similarity: Canine, Bovine

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Scientific Data Images for IDH2 Antibody

Western Blot: IDH2 Antibody [NBP1-52117]

Western Blot: IDH2 Antibody [NBP1-52117]

Western Blot: IDH2 Antibody [NBP1-52117] - 0.1ug/ml staining of Mouse (A), Rat (B) and Pig (C) Heart lysates (35ug protein in RIPA buffer). Detected by chemiluminescence.
Immunohistochemistry-Paraffin: IDH2 Antibody [NBP1-52117]

Immunohistochemistry-Paraffin: IDH2 Antibody [NBP1-52117]

Immunohistochemistry-Paraffin: IDH2 Antibody [NBP1-52117] - 3.75ug/ml staining of paraffin embedded Human Skeletal Muscle. Steamed antigen retrieval with citrate buffer pH 6, AP-staining.
Western Blot: IDH2 Antibody [NBP1-52117]

Western Blot: IDH2 Antibody [NBP1-52117]

Western Blot: IDH2 Antibody [NBP1-52117] - Analysis of IDH2 in Human Heart lysate (35ug protein in RIPA buffer) using NBP1-52117 at 0.1 ug/ml. Primary incubation was 1 hour. Detected by chemiluminescence.

Applications for IDH2 Antibody

Application
Recommended Usage

Immunohistochemistry

3.75 ug/ml

Immunohistochemistry-Paraffin

3.75 ug/ml

Peptide ELISA

Detection limit 1:16000

Western Blot

0.1-0.3 ug/ml
Application Notes
Western blot: Approx 48kDa band observed in Mouse, Rat and Pig Heart lysates (calculated MW of 50.9kDa according to Mouse NP_766599.2). Primary incubation was 1 hour
IHC: Paraffin embedded Human Skeletal Muscle.
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Formulation

Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA

Preservative

0.02% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at -20C. Avoid freeze-thaw cycles.

Background: IDH2

Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. Each NADP(+)-dependent isozyme is a homodimer. The protein encoded by this gene is the NADP(+)-dependent isocitrate dehydrogenase found in the mitochondria. It plays a role in intermediary metabolism and energy production. This protein may tightly associate or interact with the pyruvate dehydrogenase complex.

Alternate Names

D2HGA2, EC 1.1.1.42, ICD-M, IDH, IDHM, IDP, IDPM, isocitrate dehydrogenase [NADP], mitochondrial, isocitrate dehydrogenase 2 (NADP+), mitochondrial, mNADP-IDH, NADP(+)-specific ICDH, Oxalosuccinate decarboxylase

Entrez Gene IDs

3418 (Human); 269951 (Mouse); 361596 (Rat)

Gene Symbol

IDH2

UniProt

Additional IDH2 Products

Product Documents for IDH2 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for IDH2 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...